Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib plus Gemcitabine in Advanced Pancreatic Cancer
NCT00005648Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tipifarnib in pancreatic cancer (PC), sponsored by Johnson & Johnson. Started Nov 1999; status: completed.
02
Drugs
tipifarnib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00005648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005648.